Requires the registration of chain and community pharmacies.
Summary
S10238 would amend the Education Law to create a new registration system for chain and community pharmacies in New York. It defines “chain pharmacy” as a publicly traded company with at least 20 licensed pharmacies in the state under common ownership, and “community pharmacy” as a privately held company with fewer than 20 licensed pharmacies under common ownership. The bill also excludes several types of pharmacies from the community pharmacy category, including government-owned, hospital-owned, supermarket or general merchandise store pharmacies, medical practice or clinic extensions, out-of-state corporate chains, mail-order pharmacies, and pharmacies owned by pharmacy benefit managers or health insurers.
Under the bill, each chain or community pharmacy would need to apply to the Department of Education for designation, using a form prescribed by the department, and renew that designation every three years. The application would require a $500 fee. The bill would take effect 90 days after becoming law, with immediate authorization for any necessary implementing regulations.
Impact
The bill would add a new regulatory layer to section 6808 of the Education Law by requiring certain pharmacies to register and obtain formal designation as either chain or community pharmacies. This would affect pharmacy owners operating in New York, particularly publicly traded chains and smaller privately held pharmacies, while excluding several other pharmacy models from the community pharmacy category. The Department of Education would be responsible for administering the designation process and collecting the fee, and the bill would likely create a new compliance obligation for covered pharmacies.
Sentiment
No committee transcript or vote record is available for this bill, so there is no direct evidence of debate, support, or opposition in the provided materials. Based on the text alone, the bill appears to be a regulatory and classification measure rather than a substantive change to pharmacy practice, suggesting a neutral-to-administrative policy approach. Any public sentiment would likely depend on whether stakeholders view the registration requirement as useful oversight or as an added burden on pharmacy operators.
Contention
The main points of potential contention are the bill’s definitions and exclusions, especially the distinction between chain and community pharmacies and the decision to exclude pharmacies owned by PBMs, insurers, supermarkets, hospitals, mail-order operators, and out-of-state chains from the community pharmacy category. Pharmacy owners may also object to the $500 fee and the three-year renewal requirement as additional administrative costs. Conversely, supporters may argue that the registration system improves transparency and helps state regulators better understand pharmacy ownership structures.
Requires pharmacies that are permanently discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.
Requires pharmacies that are permanently discontinuing to notify customers of such discontinuance and provide information including locations of other nearby pharmacies.
Authorizes registered pharmacy technicians to administer the same immunizations as licensed pharmacists under direct supervision of such licensed pharmacist.
Authorizes registered pharmacy technicians to administer the same immunizations as licensed pharmacists under direct supervision of such licensed pharmacist.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.
Enacts the "foreign drug transparency act" to provide information on the origin, manufacture and distribution of prescription drugs; requires a pharmacy benefit manager to maintain, and make available to pharmacies, health plans, and patients upon request, supply chain information for prescription drugs covered under its network.